First line nucleos(t)ide analog monotherapy is more cost-effective than combination strategies in hepatitis B e antigen-positive chronic hepatitis B patients in China

著录项

• 来源
  《中华医学杂志（英文版）》 |2019年第19期|2315-2324|共10页
• 作者

  Xue-Ru Yin; Jin-Lin Hou; Zhi-Hong Liu; Jing Liu; Yuan-Yuan Liu; Li Xie; Li-Bo Tao; Ji-Dong Jia; Fu-Qiang Cui; Gui-Hua Zhuang;

  展开▼
• 作者单位

  Hepatology Unit Department of Infectious Diseases Nanfang Hospital Southern Medical University Guangzhou Guangdong 510515 China;

  Health Economics Research Institute Sun Yat-Sen University Guangzhou Guangdong 510085 China;

  Department of Epidemiology and Biostatistics School of Public Health Xi'an Jiao Tong University Health Science Center Xi'an Shaanxi 710061 China;

  Liver Research Center Beijing Friendship Hospital Capital Medical University Beijing 100050 China;

  School of Public Health Peking University Beijing 100191 China;

  School of Public Health Xi'an Jiao Tong University Health Science Center Xi'an Shaanxi 710061 China;

  展开▼
• 原文格式 PDF
• 正文语种 eng
• 中图分类
• 关键词